Avanos Medical, Inc. (AVNS) Misses Q3 EPS by 1c, Lowers Guidance
Avanos Medical, Inc. (NYSE: AVNS) reported Q3 EPS of $0.30, $0.01 worse than the analyst estimate of $0.31. Revenue for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
